SGP

Supergroup (SGP)

Supergroup

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:SGP

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2009/11/02	07 : 00	PR Newswire (US)	Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Ann	NYSE:SGP
2009/10/31	03 : 12	PR Newswire (US)	U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma	NYSE:SGP
2009/10/30	22 : 31	PR Newswire (US)	Critical Alerts for Cisco, Schering-Plough, BHP Billiton, Costco, and American Eagle Released by Seven Summits Research	NYSE:SGP
2009/10/30	07 : 11	Dow Jones News	Priceline.com To Replace Schering-Plough In S&P 500 Index	NYSE:SGP	Schering-Plough Corp.
2009/10/30	06 : 24	Dow Jones News	UPDATE: US FTC Clears Merck-Schering Deal, With Conditions	NYSE:SGP	Schering-Plough Corp.
2009/10/30	05 : 43	Dow Jones News	US FTC Clears Merck-Schering Deal, With Conditions	NYSE:SGP	Schering-Plough Corp.
2009/10/19	21 : 58	Dow Jones News	J&J, Schering Arthritis Drug Shows Success In Stopping Damage	NYSE:SGP	Schering-Plough Corp.
2009/10/15	21 : 30	PR Newswire (US)	Schering-Plough Highlights Boceprevir, Narlaprevir (SCH 900518) and PEGINTRON(R) Data at the American Association for the Study	NYSE:SGP
2009/10/14	13 : 58	Dow Jones News	Australian Regulator Oks Schering-Plough Acquisition Of Merck	NYSE:SGP	Schering-Plough Corp.
2009/10/08	21 : 37	PR Newswire (US)	Intervet/Schering-Plough Animal Health Announces Sponsorship Supporting Milk Producers In Malawi	NYSE:SGP
2009/10/08	00 : 49	Dow Jones News	Doctors, Drug Executives Say Reform Won't Cure Health Care's Ills	NYSE:SGP	Schering-Plough Corp.
2009/10/07	22 : 31	PR Newswire (US)	Critical Alerts for Microsoft, Schering-Plough, Yamana Gold, Whole Foods, and Chalco Released by Seven Summits Research	NYSE:SGP
2009/10/07	04 : 17	Dow Jones News	Schering CEO Warns Of Loss Of Innovation In Drug Cos' Deals	NYSE:SGP	Schering-Plough Corp.
2009/10/06	02 : 49	Dow Jones News	UPDATE: FDA Panel Narrowly Backs Schering's Pegintron For Melanoma	NYSE:SGP	Schering-Plough Corp.
2009/10/06	01 : 16	Dow Jones News	FDA Panel Narrowly Backs Schering's Pegintron For Melanoma	NYSE:SGP	Schering-Plough Corp.
2009/09/28	22 : 01	Dow Jones News	Merck To Sell CSL's Flu Vaccine In US Starting Next Year	NYSE:SGP	Schering-Plough Corp.
2009/09/24	03 : 43	Dow Jones News	Schering's Hassan Stresses Innovation In Success For Pharma	NYSE:SGP	Schering-Plough Corp.
2009/09/22	07 : 39	Dow Jones News	Boehringer Ingelheim To Acquire Wyeth's Animal Health Assets	NYSE:SGP	Schering-Plough Corp.
2009/09/15	06 : 02	Dow Jones News	Schering, Merck Spent $60 Million On Medical Education For Doctors	NYSE:SGP	Schering-Plough Corp.
2009/09/11	07 : 34	Dow Jones News	J&J's Centocor Unit Gets FDA Response Letter On Doxil	NYSE:SGP	Schering-Plough Corp.
2009/09/03	17 : 31	Dow Jones News	CORRECT: Dainippon Sumitomo In Talks To Buy Sepracor	NYSE:SGP	Schering-Plough Corp.
2009/09/03	13 : 39	Dow Jones News	2nd UPDATE: Dainippon Sumitomo In Talks To Buy Sepracor	NYSE:SGP	Schering-Plough Corp.
2009/09/03	12 : 10	Dow Jones News	UPDATE: Dainippon Sumitomo In Talks To By Sepracor	NYSE:SGP	Schering-Plough Corp.
2009/09/01	08 : 13	Dow Jones News	UPDATE: US Court Denies Schering-Plough $473 Million Tax Refund	NYSE:SGP	Schering-Plough Corp.
2009/09/01	07 : 28	Dow Jones News	US Court Denies Schering-Plough $473 Million Tax Refund	NYSE:SGP	Schering-Plough Corp.
2009/09/01	02 : 59	Dow Jones News	UPDATE: Merck Names New Management Team For Combined Co	NYSE:SGP	Schering-Plough Corp.
2009/08/31	22 : 44	Dow Jones News	Merck Names New Management Team For Combined Co.	NYSE:SGP	Schering-Plough Corp.
2009/08/30	21 : 27	Dow Jones News	Sanofi-Aventis Reports Phase II Trial Success For Otamixiban	NYSE:SGP	Schering-Plough Corp.
2009/08/15	00 : 29	Dow Jones News	SUBSCRIBERS: FDA OKs Saphris News Already Reported	NYSE:SGP	Schering-Plough Corp.
2009/08/14	21 : 00	Dow Jones News	FDA OKs Schering-Plough Drug For Schizophrenia, Bipolar	NYSE:SGP	Schering-Plough Corp.